Public disclosures

LPCN insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Higuchi John W.

Director · Lipocine Inc.

LPCN

Lipocine Inc.

Buy
Filing details

SEC transaction code P

Common stock · Direct ownership · Reported balance after transaction: 391365 · SEC code covers open-market or private transactions

2026-11-202026-11-20

≈ $111,832.50

75,000 shares/units

SEC 4Follow
Higuchi John W.

Director · Lipocine Inc.

LPCN

Lipocine Inc.

Buy
Filing details

SEC transaction code P

Common stock · Direct ownership · Reported balance after transaction: 316365 · SEC code covers open-market or private transactions

2026-11-192026-11-20

≈ $113,392.50

75,000 shares/units

SEC 4Follow
Patel Mahesh V.

Chief Executive Officer · Director · Lipocine Inc.

LPCN

Lipocine Inc.

Buy
Filing details

SEC transaction code P

Common stock · Direct ownership · Reported balance after transaction: 211495 · SEC code covers open-market or private transactions

2026-11-132026-11-13

≈ $39,997.50

25,000 shares/units

SEC 4Follow
Patel Mahesh V.

Chief Executive Officer · Director · Lipocine Inc.

LPCN

Lipocine Inc.

Buy
Filing details

SEC transaction code P

Common stock · Direct ownership · Reported balance after transaction: 186495 · SEC code covers open-market or private transactions

2026-11-122026-11-13

≈ $39,490.00

25,000 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement